Clinical trial Recruiting at 1 site Interventional Ages 10 to 20

Assessing social cognition in children with autism using MRI and eye tracking

Official title: MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD

Run by Centre Hospitalier Universitaire, Amiens · NCT05194254 · Data updated 2026-11-12

This study is trying to see how children with autism understand social situations by using MRI and eye tracking to watch how their attention to others changes as they grow up.

More ASD trials

Quick facts

Study typeInterventional
Ages10 Years to 20 Years
SexAll
Enrollment68 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens, Picardie)
StatusRecruiting
StartedJanuary 4, 2022
Main results expectedJune 2025
Study endsJune 2025
Registry record updatedMay 28, 2025
Trial IDNCT05194254 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 10 to 20 years with a diagnosis of Autism Spectrum Disorder.

Probably not a fit

Patients outside the age range of 10 to 20 years or those without a diagnosis of ASD may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the assessment of social cognition in children with Autism Spectrum Disorders (ASD) by utilizing a novel approach that combines MRI and eye tracking technology. By creating video-based visual percepts that closely mimic real-life social interactions, the study seeks to better understand how joint attention develops over time in autistic children. The research will longitudinally explore the neurodevelopmental aspects of social cognition, addressing a gap in existing literature regarding the influence of age on joint attention perception in individuals with ASD.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic tools and interventions for enhancing social cognition in children with autism.

How similar studies have gone: While the approach of using MRI and eye tracking is innovative, similar studies have not been widely conducted, making this a novel exploration in the field.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For the group of people with Autism Spectrum Disorders (experimental group):

* Age between 10 to 20 years old
* Diagnosis of ASD (CARS) ≥ 30 performed at inclusion
* IQ test evaluation (regardless of the result) performed by a trained psychologist
* Obtaining informed oral and written consent after appropriate information
* Obtaining informed oral and written consent from the legal guardian after information
* Be affiliated with social security
* No contraindication to magnetic resonance imaging

For the TD (Typical Development) group of people (control group):

* Age between 10 to 20 years old
* Diagnosis of ASD (CARS) \<30 performed at inclusion
* IQ test evaluation (regardless of the result) performed by a trained psychologist
* Obtaining informed oral and written consent after appropriate information
* Obtaining informed oral and written consent from the legal guardian after information
* Be affiliated with social security
* No contraindication to magnetic resonance imaging

Exclusion Criteria:

For all groups:

* Age outside the range 10 to 20 years
* Person with a contraindication to MRI (including claustrophobia, pace maker, neurosurgical clips, vascular clips, heart valves, ventriculoperitoneal valves, cochlear implant, neurostimulator, intraocular metal shards, joint prosthesis, etc.)
* Person suffering from major obesity (\> 140 kg) not allowing him to enter the tunnel of the MRI machine (diameter \<70cm)
* Pregnant or breastfeeding woman
* Person under guardianship or guardianship or deprived of liberty by a judicial or administrative decision

For TD people (control group):

* Person with psychiatric disorders such as attention disorder with or without hyperactivity, depression, bipolar disorder and schizophrenia.
* Person with a neurological history such as epilepsy and / or neurovascular accident.

Where it's running

  • CHU Amiens Picardie
    Amiens, Picardie, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.